270 related articles for article (PubMed ID: 33596994)
1. BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
Giles KA; Gould CM; Achinger-Kawecka J; Page SG; Kafer GR; Rogers S; Luu PL; Cesare AJ; Clark SJ; Taberlay PC
Clin Epigenetics; 2021 Feb; 13(1):37. PubMed ID: 33596994
[TBL] [Abstract][Full Text] [Related]
2. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
Medina PP; Sanchez-Cespedes M
Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
[TBL] [Abstract][Full Text] [Related]
5. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
[TBL] [Abstract][Full Text] [Related]
6. SMARCA4 regulates gene expression and higher-order chromatin structure in proliferating mammary epithelial cells.
Barutcu AR; Lajoie BR; Fritz AJ; McCord RP; Nickerson JA; van Wijnen AJ; Lian JB; Stein JL; Dekker J; Stein GS; Imbalzano AN
Genome Res; 2016 Sep; 26(9):1188-201. PubMed ID: 27435934
[TBL] [Abstract][Full Text] [Related]
7. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of BRG1 silencing in primary cancers.
Marquez-Vilendrer SB; Thompson K; Lu L; Reisman D
Oncotarget; 2016 Aug; 7(35):56153-56169. PubMed ID: 27486753
[TBL] [Abstract][Full Text] [Related]
9. The chromatin remodeling protein BRG1 links ELOVL3 trans-activation to prostate cancer metastasis.
Yang Y; Liu L; Li M; Cheng X; Fang M; Zeng Q; Xu Y
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):834-845. PubMed ID: 31154107
[TBL] [Abstract][Full Text] [Related]
10. Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.
Song S; Nguyen V; Schrank T; Mulvaney K; Walter V; Wei D; Orvis T; Desai N; Zhang J; Hayes DN; Zheng Y; Major MB; Weissman BE
Mol Cancer Res; 2020 Dec; 18(12):1777-1788. PubMed ID: 32855269
[TBL] [Abstract][Full Text] [Related]
11. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
12. The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.
Wu Q; Madany P; Akech J; Dobson JR; Douthwright S; Browne G; Colby JL; Winter GE; Bradner JE; Pratap J; Sluder G; Bhargava R; Chiosea SI; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Nickerson JA; Imbalzano AN
J Cell Physiol; 2015 Nov; 230(11):2683-94. PubMed ID: 25808524
[TBL] [Abstract][Full Text] [Related]
13. Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.
Raab JR; Runge JS; Spear CC; Magnuson T
Epigenetics Chromatin; 2017 Dec; 10(1):62. PubMed ID: 29273066
[TBL] [Abstract][Full Text] [Related]
14. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
15. Targeting of BRM Sensitizes
Zernickel E; Sak A; Riaz A; Klein D; Groneberg M; Stuschke M
Mol Cancer Ther; 2019 Mar; 18(3):656-666. PubMed ID: 30478150
[TBL] [Abstract][Full Text] [Related]
16. BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.
Orvis T; Hepperla A; Walter V; Song S; Simon J; Parker J; Wilkerson MD; Desai N; Major MB; Hayes DN; Davis IJ; Weissman B
Cancer Res; 2014 Nov; 74(22):6486-6498. PubMed ID: 25115300
[TBL] [Abstract][Full Text] [Related]
17. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
[TBL] [Abstract][Full Text] [Related]
18. BRG1 mutations found in human cancer cell lines inactivate Rb-mediated cell-cycle arrest.
Bartlett C; Orvis TJ; Rosson GS; Weissman BE
J Cell Physiol; 2011 Aug; 226(8):1989-97. PubMed ID: 21520050
[TBL] [Abstract][Full Text] [Related]
19. p63 and Brg1 control developmentally regulated higher-order chromatin remodelling at the epidermal differentiation complex locus in epidermal progenitor cells.
Mardaryev AN; Gdula MR; Yarker JL; Emelianov VU; Poterlowicz K; Sharov AA; Sharova TY; Scarpa JA; Joffe B; Solovei I; Chambon P; Botchkarev VA; Fessing MY
Development; 2014 Jan; 141(1):101-11. PubMed ID: 24346698
[TBL] [Abstract][Full Text] [Related]
20. Evf2 lncRNA/BRG1/DLX1 interactions reveal RNA-dependent inhibition of chromatin remodeling.
Cajigas I; Leib DE; Cochrane J; Luo H; Swyter KR; Chen S; Clark BS; Thompson J; Yates JR; Kingston RE; Kohtz JD
Development; 2015 Aug; 142(15):2641-52. PubMed ID: 26138476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
